These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38031765)

  • 1. Beta-blockers in Hypertensive Left Ventricular Hypertrophy and Atrial Fibrillation Prevention.
    Koraćević G; Mićić S; Stojanović M; Zdravkovic M; Simić D; Kostić T; Atanasković V; Janković-Tomašević R
    Curr Vasc Pharmacol; 2024; 22(1):19-27. PubMed ID: 38031765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure.
    Koracevic G; Perisic Z; Stanojkovic M; Stojanovic M; Zdravkovic M; Tomasevic M; Djordjevic D; Mladenovic K; Koracevic M; Trkulja J
    Med Princ Pract; 2022; 31(5):454-462. PubMed ID: 36044874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia.
    Koracevic G; Mićić S; Stojanovic M; Bozinovic N; Simic D; Lović D; Krstic N; Tomašević RJ
    Curr Vasc Pharmacol; 2023; 21(2):81-90. PubMed ID: 36722475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk.
    Koracevic G; Stojanovic M; Lovic D; Zdravkovic M; Sakac D
    J Hum Hypertens; 2021 Jul; 35(7):564-576. PubMed ID: 33654234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
    J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function.
    Moon J; Rim SJ; Cho IJ; Lee SH; Choi S; Chung WJ; Byun YS; Ryu SK; Pyun WB; Kim JY
    Clin Exp Hypertens; 2010; 32(8):540-6. PubMed ID: 21091364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy and antiarrhythmic drugs in atrial fibrillation: impact on mortality.
    Chung R; Houghtaling PL; Tchou M; Niebauer MJ; Lindsay BD; Tchou PJ; Chung MK
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1338-48. PubMed ID: 24831860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.
    Minatoguchi S; Kawasaki M; Tanaka R; Yoshizane T; Ono K; Saeki M; Nagaya M; Sato H; Nishigaki K; Noda T; Zile MR; Minatoguchi S
    Heart Vessels; 2017 Oct; 32(10):1202-1213. PubMed ID: 28638961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Blockers are associated with increased B-type natriuretic peptide levels differently in men and women in heart failure with preserved ejection fraction.
    Harada E; Mizuno Y; Ishii M; Ishida T; Yamada T; Kugimiya F; Yasue H
    Am J Physiol Heart Circ Physiol; 2022 Aug; 323(2):H276-H284. PubMed ID: 35714176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blockers and cardiovascular protection: focus on left ventricular hypertrophy regression and atrial fibrillation prevention.
    Cuspidi C; Negri F; Zanchetti A
    Vasc Health Risk Manag; 2008; 4(1):67-73. PubMed ID: 18629360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pitavastatin on cardiac structure and function and on prevention of atrial fibrillation in elderly hypertensive patients: a prospective study of 2-years' follow-up.
    Warita S; Kawasaki M; Tanaka R; Ono K; Kojima T; Hirose T; Iwama M; Watanabe T; Nishigaki K; Takemura G; Noda T; Watanabe S; Minatoguchi S
    Circ J; 2012; 76(12):2755-62. PubMed ID: 22878405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF]).
    Chung S; Kim TH; Uhm JS; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Kim J; Park HW; Choi EK; Kim JB; Kim CS; Lee YS; Shim J; Joung B
    Am J Cardiol; 2020 Jan; 125(1):68-75. PubMed ID: 31699363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
    Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ
    Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps.
    Triska J; Tamargo J; Bozkurt B; Elkayam U; Taylor A; Birnbaum Y
    Cardiovasc Drugs Ther; 2023 Dec; 37(6):1205-1223. PubMed ID: 35357604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.